Evaluation of quality of life (QOL), depression prevalence and distress in diabetes mellitus diagnosed patients of a tertiary care teaching hospital - a prospective interventional analytical study

Sanjuna  A; K.S.Vasanthasena  D; Navyasree  M; Akhila P; Hemanthanissi  B; UMA SANKAR V; Madhu Chandaka

doi:10.37022/jiaps.v7i2.331

A.Sanjuna Department of Pharmacy Practice, Avanthi Institute of Pharmaceutical Sciences, Cherukupally, Chittivalasa, Bhogapuram, Vizianagaram-531162
D.K.S.Vasanthasena Department of Pharmacy Practice, Avanthi Institute of Pharmaceutical Sciences, Cherukupally, Chittivalasa, Bhogapuram, Vizianagaram-531162
M.Navyasree Department of Pharmacy, Avanthi Institute of Pharmaceutical Sciences,Vizianagaram,AP,India
P.Akhila Department of Pharmacy Practice, Avanthi Institute of Pharmaceutical Sciences, Cherukupally, Chittivalasa, Bhogapuram, Vizianagaram-531162
B.Hemanthanissi Department of Pharmacy Practice, Avanthi Institute of Pharmaceutical Sciences, Cherukupally, Chittivalasa, Bhogapuram, Vizianagaram-531162
UMA SANKAR.V Associate Professor, Department of Pharmacy Practice, Avanthi Institute of Pharmaceutical Sciences, Cherukupally, Chittivalasa, Bhogapuram, Vizianagaram-531162
Chandaka Madhu Associate Professor, Department of Pharmacology, Avanthi Institute of Pharmaceutical Sciences, Cherukupally, Chittivalasa, Bhogapuram, Vizianagaram-531162

DOI https://doi.org/10.37022/jiaps.v7i2.331

Abstract

Diabetic Mellitus is a group of metabolic disorders characterized by hyperglycaemia, which occurs due to defects in insulin secretion, insulin action, or both. Diabetics distress is an emotional distress response characterized by extreme apprehension, discomfort, or dejection due to a perceived inability to cope with the challenges and demands of living with diabetes. The goals of clinical pharmacist is to management of about medication adherence, to evaluate the quality of life, identify depression levels among diabetic patients, to identify anxiety levels in diabetic patients, to evaluate diabetic distress and its effects among diabetics. Diabetic distress is the major problem associated with diabetics which is making patients losing their self-confidence and positive attitude towards life. Due to diabetic distress, depression and anxiety significant percentage of patients work exhibited poor quality of life. Proper counselling, continuous interaction, effective therapy by the clinical pharmacists could improve patients quality of life, diabetes causative and medication adherence.

Keywords: Diabetes mellitus, Diabetic Distress, Depression, Medication Adherence, Clinical Pharmacists, Anxiety, Quality of life

Downloads

Download data is not yet available.

References

1. Nitin Chaudhary, Nidhi Tyagi. Diabetes Mellitus : An overview.2018 July - August; 7(4): 3030-3033.
2. An overview of Diabetes types and treatments. Medically reviewed by Kellywood MD wriiten by Rachel Nall. https://www.medicalnewstoday.com/articles/323627
3. Metnitz PG, Krenn CG, Stelzer H , et al. effect of renal failure requrining renal replacement therapy on outcome in critically ill patients. Crit Care Med 2002;30(9):2051-2058
4. Baynest H.W., “Classification, pathophysiology, diagnosis and management of diabetes mellitus”. Journal of Diabetes and Metabolism 2015; 6:5.
5. Main symptoms of diabetes
https://upload.wikimedia.org/wikipedia/commons/thumb/0/01/Main_symptoms_of_diabetes.svg/330px-Main_symptoms_of_diabetes.svg.png
6. Maryam Saadatmand, Mohammad J. Abdekhodaie, Mahmoud R. Pishvaie, Fathollah Farhadi Journal of Biomedical Science and Engineering, Vol.7 No.9, July 21, 2014
7. Nazmul Hussain, Md Faruk Hossain, Tania Rahman,Sharif Neaz. Diabetes mellitus:Insights from epidemiology,biochemistry,risk factors,diagnosis,complications and comprehensive management.2021:2(2),36-50.
8. "Diabetes - long-term effects". betterhealth.vic.gov.au.
9. Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, Di Angelantonio E, et al. (June 2010). "Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies". Lancet. 375 (9733):2215–2222. doi:10.1016/S0140-6736(10)60484-9. PMC 2904878. PMID 20609967
10. Insulin Basics". American Diabetes Association. Archived from the original on 14 February 2014. Retrieved 24 April 2014
11. Shoback DG, Gardner D, eds. (2011). Greenspan's basic & clinical endocrinology (9th ed.). McGraw-Hill Medical. ISBN 978-0-07-162243-1
12. Barrett KE, et al. (2012). Ganong's review of medical physiology (24th ed.). McGraw-Hill Medical. ISBN 978-0-07-178003-2
13. Pathogenesis and pathophysiology of type1 and type2 diabetes mellitus BY -jevas Chibuike,kc.obimba,cb.unakalamba. 2013 Sep: (4),pp 46-57.
14. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: Report of a WHO/IDF consultation (PDF). Geneva: World Health Organization. 2006. p. 21. ISBN 978-92-4-159493-6
15. Vijan S (March 2010). "In the clinic. Type 2 diabetes". Annals of Internal Medicine. 152 (5): ITC31-15, quiz ITC316. doi:10.7326/0003-4819-152-5-201003020-01003. PMID 20194231.
16. American Diabetes Association. Standards of medical care in diabetes-2017.Diabetes Care 2017; 40 Suppl 1:S39-40
17. Fisher L, Glasgow RE, Mullan JT, Skaff MM, Polonsky WH. Development of a brief diabetes distress screening instrument. Ann Fam Med. 2008 May-Jun;6(3):246-52. doi: 10.1370/afm.842. PMID: 18474888; PMCID: PMC2384991.
18. Fisher L, Glasgow R, Mullan J, Skaff M, Polonsky W. Development of a Brief Diabetes Distress Screening Instrument. Annals of Family Medicine. 2008;6:246–252. [PMC free article] [PubMed] [Google Scholar]
19. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983;67:361–370.
20. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res 2002;52:69–77.
21. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487-497. https://journalce.powerpak.com/ce/medicationadherenceinpatientswithtype2diabetes
22. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353(5):487-497 [PubMed] [Google Scholar] [Ref list]
23. world health organization, WHOQOL-BREF: Introduction, administration, scoring, and generic version of te assessment: field trial version, December
24. Correr CJ, Pontarolo R, Melchiors AC, Rossignoli P, Fernández-Llimós F, Radominski RB. Tradução para o português e validação do instrumento Diabetes Quality of Life Measure (DQOL-Brasil). Arq Bras Endocrinol Metab 2008; 52(3): 515-22.
25. Brasil F, Pontarolo R, Correr CJ. Qualidade de vida em adultos com diabetes tipo 1 e validade do DQOL-Brasil. Rev Ciênc Farm Básica Apl 2014; 35(1): 105-12.